Description
TAMSULOSIN HCL 0.4MG CAPS NDC# 68382-132-01
First action · last action
2014-09-05 · 2014-09-05
Transactions
1
First transaction's obligation
$187,200
Base + all options value (sum of deltas)
$187,200
Extent competed
FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-09-05+$187,200= $187,200
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-09-05 | +$187,200 | $187,200 | TAMSULOSIN HCL 0.4MG CAPS NDC# 68382-132-01 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PUM1KHA7QA79)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77025P0226 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $289,027 | FY2025 |
| 36F79725D0072 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $0 | FY2025 |
| 36F79724D0032 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36F79724D0004 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2024 |
| 36C77022P0383 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $21,067 | FY2022 |
| 36C77022P0319 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $66,420 | FY2022 |
Other recipients under 6505 from 255-NETWORK CONTRACT OFFICE 15 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25516F2412 | BAYER HEALTHCARE PHARMACEUTICALS INC | 255-NETWORK CONTRACT OFFICE 15 | $51,581 | FY2016 |
| VA25516F2420 | CSL BEHRING L.L.C. | 255-NETWORK CONTRACT OFFICE 15 | $5,811 | FY2016 |
| VA25516P2404 | MCKESSON PLASMA AND BIOLOGICS LLC | 255-NETWORK CONTRACT OFFICE 15 | $10,851 | FY2016 |
| VA25516J2221 | RED RIVER PHARMACY OF JONESBORO, LLC | 255-NETWORK CONTRACT OFFICE 15 | $187,797 | FY2016 |
| VA25516D0093 | RED RIVER PHARMACY OF JONESBORO, LLC | 255-NETWORK CONTRACT OFFICE 15 | $0 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25514P6049_3600_-NONE-_-NONE- · retrieved 2026-09-26.